ARTICLE | Company News
Summit, University of Oxford deal
December 9, 2013 8:00 AM UTC
Summit and the university partnered to develop treatments for Duchenne muscular dystrophy (DMD). Under the deal, Summit will acquire MuOx Ltd., an Oxford spinout that houses exclusive rights to utroph...